| 摘要 |
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
|
| 申请人 |
ARRAY BIOPHARMA INC.;GENENTECH, INC. |
发明人 |
AHRENDT, KATERI A.;BUCKMELTER, ALEXANDRE J.;GRINA, JONAS;HANSEN, JOSHUA D.;LAIRD, ELLEN R.;NEWHOUSE, BRAD;REN, LI;WENGLOWSKY, STEVEN M.;FENG, BAINIAN;MALESKY, KIM;MATHIEU, SIMON;RUDOLPH, JOACHIM;WEN, ZHAOYANG;YOUNG, WENDY B.;MORENO, DAVID A. |
